Current processes for patient follow-up in post-acute settings following hematopoietic cell transplant, typically rely on methods such as phone calls, emails, and in some cases, searching social media for basic information such as survival.  Through collaboration with Citus Health, WellSky’s Biotherapies system will now deliver new options for care providers in this space to support ongoing communication with patients and enhanced data sharing methods in post-acute settings.  Join Rob Stoltz, Vice President of Business Development at Citus Health, as we explore the role of digital solutions in supporting patient follow-up, treatment plan adherence, and enhanced donor engagement.